Avacta and Daewoong sign collaboration and license agreement with AffyXell
LONDON: Avacta Group plc has signed a collaboration and license agreement with AffyXell Therapeutics, the recently established joint venture with Daewoong Pharmaceutical, to develop Affimer proteins to be used by…